For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Real-time PCR or quantitative PCR is a well-established technology that has become the tool of choice for the rapid, sensitive quantification of nucleic acid in various biological samples. qPCR measures the accumulation of DNA during a PCR reaction. The increase in quantity of DNA at each cycle is measured by the change in intensity of a fluorescent signal. Comparison to a reference sample determines the number of original copies of template DNA in the reaction.Digital PCR is a highly precise approach to sensitive nucleic acid detection and quantification. Each sample is partitioned into thousands of individual reactions (droplets for Droplet Digital PCR technology). Each partition is analyzed after end-point PCR cycling for the presence or absence of a fluorescent signal, and the absolute number of molecules present in the sample is calculated. dPCR does not require a standard curve for quantification.Both quantitative PCR (qPCR) and digital PCR (dPCR) provide sensitive and specific detection, and precise quantification of nucleic acids. Both technologies have similarities, but they have differences that make one or the other the more adapted choice for specific applications.
LPI (LP Information)' newest research report, the "Real-time PCR (qPCR) and Digital PCR (dPCR) Industry Forecast" looks at past sales and reviews total world Real-time PCR (qPCR) and Digital PCR (dPCR) sales in 2022, providing a comprehensive analysis by region and market sector of projected Real-time PCR (qPCR) and Digital PCR (dPCR) sales for 2023 through 2029. With Real-time PCR (qPCR) and Digital PCR (dPCR) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Real-time PCR (qPCR) and Digital PCR (dPCR) industry.
This Insight Report provides a comprehensive analysis of the global Real-time PCR (qPCR) and Digital PCR (dPCR) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Real-time PCR (qPCR) and Digital PCR (dPCR) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Real-time PCR (qPCR) and Digital PCR (dPCR) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Real-time PCR (qPCR) and Digital PCR (dPCR) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Real-time PCR (qPCR) and Digital PCR (dPCR).
The global Real-time PCR (qPCR) and Digital PCR (dPCR) market size is projected to grow from US$ 1286.4 million in 2022 to US$ 1936.4 million in 2029; it is expected to grow at a CAGR of 6.0% from 2023 to 2029.
Global Digital PCR (DPCR) and QPCR key players include Thermo Fisher, Roche, QIAGEN, Bio-rad, Agilent, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share about 50%, followed by Europe and China, both have a share about 40 percent.
In terms of product, qPCR is the largest segment, with a share about 70%. And in terms of application, the largest application is Research Use, followed by Clinical Use.
This report presents a comprehensive overview, market shares, and growth opportunities of Real-time PCR (qPCR) and Digital PCR (dPCR) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Digital Microfluidic Chip PCR
- Droplet Digital PCR
Segmentation by application
- Medical Institutions
- Universities and Research Institutes
- Government
- Other
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Thermo Fisher
- Bio-rad